Latest On Sinopharm Group Co., Ltd (SHTDY):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-06-15 06:01 EST | Dividend | A dividend of $0.6 has been announced on Mar 27, 2023. It will be paid Aug 29, 2023 with an ex-dividend date of Jun 15, 2023. | Neutral |  |
| 2023-04-13 13:53 EST | News | Pfizer collaborates with Sinopharm to expand in China | N/A | |
| 2023-02-24 11:53 EST | News | GE HealthCare and Sinopharm to form joint venture in China | N/A | |
| 2023-01-20 12:56 EST | News | Sinopharm unit cleared to study first mRNA COVID shot in China | N/A | |
| 2023-01-11 17:24 EST | News | Merck mulls legal action against unsanctioned distributors of its COVID drug in China | N/A | |
| 2022-10-08 00:25 EST | News | U.S. report says COVID vaccines led to over 300K fewer deaths among Medicare beneficiaries | N/A | |
| 2022-07-07 06:45 EST | News | Sinopharm mulls $1B acquisition of Shanghai-based BBI Life Sciences - Bloomberg | N/A | |
| 2022-06-24 05:59 EST | Dividend | A dividend of $0.59 has been announced on Mar 22, 2022. It will be paid Nov 30, -0001 with an ex-dividend date of Jun 24, 2022. | Neutral | |
| 2022-04-08 08:38 EST | News | Supply chain on watch as Shanghai lockdown grows in severity | N/A | |
| 2022-02-07 14:55 EST | News | South African regulator registers Chinese Sinopharm vaccine, Pfizer/BioNTech's COMIRNATY | N/A | |
| 2021-10-12 17:08 EST | News | WHO recommends an additional COVID-19 vaccine for immunocompromised people | N/A | |
| 2021-09-22 14:32 EST | News | Small study indicates benefit of Sinopharm COVID booster shot | N/A | |
| 2021-09-04 03:08 EST | News | China is struggling to expand COVID-19 vaccination drive - official | N/A | |
| 2021-08-03 04:10 EST | News | Sinopharm COVID-19 shot offers a lower antibody response against Delta variant - study | N/A | |
| 2021-07-22 13:13 EST | News | Sinopharm: Good Share Price Run Has Halted | N/A | |
| 2021-07-22 13:13 EST | News | Chinese COVID-19 shots have nearly 70% efficacy against Delta variant, scientist says | N/A | |
| 2021-06-14 06:10 EST | Dividend | A dividend of $0.53 has been announced on Nov 30, -0001. It will be paid Aug 25, 2021 with an ex-dividend date of Jun 14, 2021. | Neutral | |
| 2021-04-25 15:46 EST | News | Diversifying Into Top-Ranked Sinopharm | N/A | |
| 2021-03-26 01:19 EST | News | Sinopharm: 2020 Results And Recent Centralized Drug Procurement Draw Attention | N/A | |
| 2020-11-26 22:57 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-08 01:59 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-07 18:21 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-02 05:32 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-26 15:13 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-23 10:52 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-17 07:20 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-26 06:48 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-24 21:05 EST | News | Sinopharm Group Co., Ltd. 2020 Q2 - Results - Earnings Call Presentation | N/A | |
| 2020-08-19 01:25 EST | News | SinoPharm's Inactivated Coronavirus Vaccine | N/A | |
| 2020-08-14 11:16 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-06 14:51 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-06 10:37 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-30 19:01 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-30 06:59 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-29 23:12 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-27 14:51 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-23 19:38 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-09 11:04 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-01 18:47 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-01 02:34 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-19 14:41 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-14 06:47 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-12 08:22 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-12 06:06 EST | Dividend | A dividend of $0.42 has been announced on Jun 4, 2020. It will be paid Aug 26, 2020 with an ex-dividend date of Jun 12, 2020. | Neutral | |
| 2020-05-28 05:55 EST | News | Go Long On SinoPharm Group's HKEX Ticker 1099:HK | N/A | |
| 2020-05-27 07:24 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-21 02:59 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-06 07:40 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-01 18:35 EST | Financials | Company financials have been released. | Neutral | |
| 2020-04-20 06:23 EST | Financials | Company financials have been released. | Neutral | |
About Sinopharm Group Co., Ltd (SHTDY):
Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and healthcare products in the People's Republic of China. Its Pharmaceutical Distribution segment distributes pharmaceutical products to hospitals, other distributors, retail drug stores, and clinics. This segment also offers distribution, logistics, and other value-added services for domestic and international pharmaceutical and healthcare products manufacturers, and other suppliers. The company's Retail Pharmacy segment operates and franchises a network of retail drug stores. As of December 31, 2019, this segment had 5,021 retail pharmacies. Its Medical Devices segment distributes medical devices. The company's Other Business segment engages in the production and sale of pharmaceutical products, chemical reagents, and laboratory supplies. The company also rents and manages properties; distributes medical instruments, Chinese herbal medicines, antibiotics, and biological products; and offers information technology development and medicine consultation, investment, goods and technology import and export, business consultation, health consultation, medical consultation, market information consultation and investigation, and convention and exhibition services. In addition, it manages medical project investment, consulting, and technology training activities, as well as offers cleaning and sterilization services for medical instruments and devices. The company was founded in 2003 and is headquartered in Shanghai, the People's Republic of China.
General
- Name Sinopharm Group Co., Ltd
- Symbol SHTDY
- Type Common Stock
- Exchange PINK
- Currency USD
- Country USA
- SectorHealthcare
- IndustryMedical Distribution
- Full Time Employees 93,764
- Fiscal Year EndDecember
- Web URLhttp://www.sinopharmgroup.com.cn
View More
Valuation
- Trailing PE 8.13
- Forward PE 6.9
- Price/Sales (Trailing 12 Mt.) 0.11
- Price/Book (Most Recent Quarter) 0.85
- Enterprise Value Revenue 0.03
- Enterprise Value EBITDA 0.7
View More
Financials
- Most Recent Quarter 2020-09-30
- Profit Margin 2%
- Return on Assets 4%
- Return on Equity 14%
- Earnings Per Share $1.43
- Revenue Per Share $0
- Gross Profit 37.53 billion
- Quarterly Earnings Growth 11.5%
View More
Highlights
- Market Capitalization 6.95 billion
- PEG Ratio 49.31
- Book Value Per Share $10.00
View More
Share Statistics
- Shares Outstanding 594.33 million
- Shares Float 237.01 million
- % Held by Insiders <1%
- % Held by Institutions 0.04%
View More
Technicals
- Beta 0.75
- 52 Week High $14.35
- 52 Week Low $9.4
- 50 Day Moving Average 11.88
- 200 Day Moving Average 11.78
View More
Dividends
- Forward Annual Dividend Rate $0.42
- Forward Annual Dividend Yield 3.69%
- Payout Ratio 240%
- Dividend Date 2020-08-26
- ExDividend Date 2020-06-12
- Dividend Per Share $0.09
- Dividend Yield 0%
View More
Sinopharm Group Co., Ltd (SHTDY) Dividend Calendar:
SHTDY's last dividend payment was made to shareholders on August 26, 2020.
Sinopharm Group Co., Ltd pays out 240% of its earnings out as a dividend.
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Sinopharm Group Co., Ltd (SHTDY) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-06-30 | 2020-09-30 | $N/A | $0.11 | $0.00 | |
| 2020-03-31 | 2020-06-30 | $N/A | $0.07 | $0.00 | |
| 2019-12-31 | 2020-03-31 | $N/A | $0.07 | $0.00 | |
| 2019-09-30 | 2019-12-31 | $111.02 billion | $0.08 | $0.00 | |
| 2019-06-30 | 2019-09-30 | $106.49 billion | $0.08 | $0.00 | |
| 2019-03-31 | 2019-06-30 | $95.18 billion | $0.09 | $0.00 | |
| 2018-12-31 | 2019-03-31 | $98.52 billion | $0.06 | $0.00 | |
| 2018-09-30 | 2018-12-31 | $87.35 billion | $0.07 | $0.00 | |
| 2018-06-30 | 2018-09-30 | $73.74 billion | $0.08 | $0.00 | |
| 2018-03-31 | 2018-06-30 | $78.94 billion | $0.09 | $0.00 | |
| 2017-12-31 | 2018-03-31 | $N/A | $0.05 | $0.00 | |
| 2017-09-30 | 2017-12-31 | $624.17 million | $0.07 | $0.00 | |
| 2017-06-30 | 2017-09-30 | $8.82 billion | $0.07 | $0.00 | |
| 2017-03-31 | 2017-06-30 | $8.86 billion | $0.07 | $0.00 | |
| 2016-12-31 | 2017-03-31 | $66.25 billion | $0.07 | $0.00 | |
| 2016-09-30 | 2016-12-31 | $66.25 billion | $0.05 | $0.00 | |
| 2016-06-30 | 2016-09-30 | $0.06 | $0.00 | ||
| 2016-03-31 | 2016-06-30 | $0.08 | $0.00 | ||
| 2015-12-31 | 2016-03-31 | $0.06 | $0.00 | ||
| 2015-09-30 | 2015-12-31 | $0.05 | $0.00 | ||
| 2015-06-30 | 2015-09-30 | $0.05 | $0.00 | ||
| 2015-03-31 | 2015-06-30 | $0.06 | $0.00 | ||
| 2014-12-31 | 2015-03-31 | $0.05 | $0.00 | ||
| 2014-09-30 | 2014-12-31 | $0.04 | $0.00 | ||
| 2014-06-30 | 2014-09-30 | $0.04 | $0.00 | ||
| 2014-03-31 | 2014-06-30 | $0.05 | $0.00 | ||
| 2013-12-31 | 2014-03-31 | $0.05 | $0.00 | ||
| 2013-09-30 | 2013-12-31 | $0.04 | $0.00 | ||
| 2013-06-30 | 2013-09-30 | $0.03 | $0.00 | ||
| 2013-03-31 | 2013-06-30 | $0.04 | $0.00 | ||
| 2012-12-31 | 2013-03-31 | $0.04 | $0.00 | ||
| 2012-09-30 | 2012-12-31 | $0.03 | $0.00 | ||
| 2012-06-30 | 2012-09-30 | $0.03 | $0.00 | ||
| 2012-03-31 | 2012-06-30 | $0.03 | $0.00 | ||
| 2011-12-31 | 2012-03-31 | $0.03 | $0.00 | ||
| 2011-09-30 | 2011-12-31 | $0.03 | $0.00 | ||
| 2011-06-30 | 2011-09-30 | $0.03 | $0.00 | ||
| 2011-03-31 | 2011-06-30 | $0.03 | $0.00 | ||
| 2010-12-31 | 2011-03-31 | $0.03 | $0.00 | ||
| 2010-09-30 | 2010-12-31 | $0.02 | $0.00 |
Sinopharm Group Co., Ltd (SHTDY) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 |
|---|---|---|---|---|---|
| Research Development | N/A | N/A | N/A | N/A | 96.78 million |
| Income Before Tax | N/A | N/A | N/A | N/A | 3.43 billion |
| Selling General Administrative | N/A | N/A | N/A | N/A | 4.44 billion |
| Gross Profit | N/A | N/A | N/A | N/A | 9.74 billion |
| Ebit | N/A | N/A | N/A | N/A | 4.38 billion |
| Operating Income | N/A | N/A | N/A | N/A | 4.38 billion |
| Income Tax Expense | 1.02 billion | 706.88 million | 706.88 million | 932.33 million | 789.31 million |
| Total Revenue | N/A | N/A | N/A | N/A | 111.02 billion |
| Cost of Revenue | N/A | N/A | N/A | N/A | 101.28 billion |
| Total Other Income Expense Net | N/A | N/A | N/A | N/A | -946.35 million |
| Net Income From Continuing Operations | N/A | N/A | N/A | N/A | 2.64 billion |
| Net Income Applicable to Common Shares | 2.06 billion | 1.45 billion | 1.45 billion | 1.66 billion | 1.62 billion |
Cash Flow:
| Date | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 |
|---|---|---|---|---|---|
| Investments | N/A | N/A | N/A | N/A | -159.61 million |
| Change to Liabilities | -697.24 million | 348.62 million | 348.62 million | N/A | N/A |
| Total Cash Flow from Investing Activities | -2.6 billion | 995.31 million | 995.31 million | -4.07 billion | -2.29 billion |
| Net Borrowings | 1.13 billion | 12.62 billion | 12.62 billion | -10.46 billion | 1.36 billion |
| Total Cash Flow from Financial Activities | N/A | N/A | N/A | N/A | -1.92 billion |
| Change to Operating Activities | -832.49 million | 416.24 million | 416.24 million | N/A | N/A |
| Change in Cash | N/A | N/A | N/A | N/A | -6.43 billion |
| Total Cash from Operating Activities | 1.33 billion | -13.8 billion | -13.8 billion | 34.34 billion | -2.22 billion |
| Depreciation | N/A | N/A | N/A | N/A | -1.33 billion |
| Other Cash Flow from Investing Activities | -148.33 million | 1.55 billion | 1.55 billion | -1.32 billion | -1.32 billion |
| Change to Inventory | N/A | N/A | N/A | N/A | N/A |
| Change to Account Receivables | N/A | N/A | N/A | N/A | N/A |
| Other Cash Flow from Financing Activities | -1.86 billion | -1.53 billion | -1.53 billion | -6.83 billion | 1.99 billion |
| Change to Net Income | -35.1 billion | 1.94 billion | 1.94 billion | 29.57 billion | -2.51 billion |
| Capital Expenditures | N/A | N/A | N/A | N/A | 687.4 million |
Balance Sheet:
| Date | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 |
|---|---|---|---|---|---|
| Total Liabailities | N/A | N/A | N/A | N/A | 213.07 billion |
| Total Stockholder Equity | N/A | N/A | N/A | N/A | 45.9 billion |
| Other Current Liabilities | 47.25 billion | N/A | N/A | N/A | 54.35 billion |
| Total Assets | N/A | N/A | N/A | N/A | 287.01 billion |
| Common Stock | 3.12 billion | 3.12 billion | 3.12 billion | 2.97 billion | 2.97 billion |
| Other Current Assets | 9.56 billion | N/A | N/A | N/A | 11.29 billion |
| Retained Earnings | 30.65 billion | N/A | N/A | N/A | 25.9 billion |
| Other Liabilities | 3.85 billion | 3.61 billion | 3.61 billion | 3.05 billion | 2.46 billion |
| Other Assets | 7.27 billion | 5.46 billion | 5.46 billion | 5.02 billion | 5.72 billion |
| Cash | N/A | N/A | N/A | N/A | 35.12 billion |
| Total Current Liabilities | 219.68 billion | N/A | N/A | N/A | 198.31 billion |
| Other Stockholder Equity | 2.81 million | 48.91 billion | 48.91 billion | 44.51 billion | -7.21 million |
| Property, Plant & Equipment | 15.98 billion | 18.22 billion | 18.22 billion | 18.06 billion | 15.17 billion |
| Total Current Assets | 280.67 billion | N/A | N/A | N/A | 248.93 billion |
| Long Term Investments | N/A | N/A | N/A | N/A | 7.61 billion |
| Net Tangible Assets | 42.16 billion | 42.24 billion | 42.24 billion | 38.43 billion | 36.32 billion |
| Short Term Investments | N/A | N/A | N/A | N/A | N/A |
| Long Term Debt | N/A | N/A | N/A | N/A | 9.41 billion |
| Inventory | 48.75 billion | N/A | N/A | N/A | 45.48 billion |
| Accounts Payable | 115.26 billion | N/A | N/A | N/A | 104.25 billion |
Sinopharm Group Co., Ltd (SHTDY) Chart:
Sinopharm Group Co., Ltd (SHTDY) News:
Below you will find a list of latest news for Sinopharm Group Co., Ltd (SHTDY) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Sinopharm Group Co., Ltd (SHTDY) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|
Sinopharm Group Co., Ltd (SHTDY) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2012-08-22 | F-6EF | Registration of American Depository Receipt shares, immediately effective | https://www.sec.gov/Archives/edgar/data/1556605/000101915512000516/0001019155-12-000516-index.htm |
| 2012-09-14 | F-6EF | Registration of American Depository Receipt shares, immediately effective | https://www.sec.gov/Archives/edgar/data/1556605/000119380512001572/0001193805-12-001572-index.htm |
| 2013-06-04 | F-6EF | Registration of American Depository Receipt shares, immediately effective | https://www.sec.gov/Archives/edgar/data/1556605/000119380513001069/0001193805-13-001069-index.htm |
| 2016-02-01 | F-6EF | Registration of American Depository Receipt shares, immediately effective | https://www.sec.gov/Archives/edgar/data/1556605/000119380516002372/0001193805-16-002372-index.htm |
| 2017-09-29 | F-6 POS | Post-effective amendments for immediately effective filing | https://www.sec.gov/Archives/edgar/data/1556605/000119380517002973/0001193805-17-002973-index.htm |
| 2019-11-22 | F-6EF | Registration of American Depository Receipt shares, immediately effective | https://www.sec.gov/Archives/edgar/data/1556605/000119380519001698/0001193805-19-001698-index.htm |